Obexelimab met the primary endpoint demonstrating a clinically meaningful and highly statistically significant 56% reduction in risk of IgG4-RD ...

Follow any beauty biohacker on social media right now and you’ll hear them raving about the benefits of red-light therapy. There's so much hype about the technology that it's fair to ask, “Does ...

Aradigm Health, a new benefits platform aimed at easing the financial sting of coverage for cell and gene therapies, has launched out of stealth. The company is making its debut backed by a $20 ...

AOM Infusion (“AOM”), a leading provider of specialty infusion and pharmacy services for chronic and complex conditions, has been selected by Kedrion Biopharma as a limited distribution network ...

On Monday, US Health and Human Services Secretary Robert F. Kennedy Jr. and US Food and Drug Administration Commissioner Dr. Marty Makary announced that after 20 years, they were righting a medical ...

Please provide your email address to receive an email when new articles are posted on . There were no serious bacterial infections or hospitalizations due to infection over 12 months among adults ...

Efgartigimod demonstrated superior efficacy over IVIG in improving MG-ADL and QMG scores in myasthenia gravis patients. Patients treated with efgartigimod experienced faster symptom improvement and ...

According to the American Society for Laser Medicine and Surgery, red light therapy—also known as photobiomodulation—uses specific wavelengths (typically 630–680 nanometers for red and 800–830 nm for ...

Kedrion Biopharma has scored an FDA approval for Qivigy for adults with primary humoral immunodeficiency (PI), a group of disorders that prevent the immune system from operating effectively. As an ...

Hot flashes and sleepless nights are just some of the symptoms of perimenopause that have been disrupting Isabel Kallman's life. At 53 years old, Kallman's hormones naturally started to decline, and ...

Please provide your email address to receive an email when new articles are posted on . Serious infections in patients with chronic lymphocytic leukemia have doubled despite increased use of ...